Back to Search Start Over

Potential health benefits of zinc supplementation for the management of COVID‐19 pandemic

Authors :
Oluwafemi Omoniyi Oguntibeju
Ademola Adetokunbo Oyagbemi
A.O. Aro
Adeolu Alex Adedapo
Temidayo Olutayo Omobowale
Fasilat Oluwakemi Hassan
Emma Thamahane-Katengua
Lyndy Joy McGaw
Blessing Seun Ogunpolu
Yapo Guillaume Aboua
Prudence Ngalula Kayoka-Kabongo
Momoh A. Yakubu
Olumuyiwa Abiola Adejumobi
Adebowale Benard Saba
Olufunke Eunice Ola-Davies
Iyanuoluwa Omolola Ogunmiluyi
Olufunke Olubunmi Falayi
Aduragbenro D.A. Adedapo
Taiwo Olaide Oyagbemi
Temitayo Olabisi Ajibade
Idayat Titilayo Gbadamosi
Sanah M. Nkadimeng
Source :
Journal of Food Biochemistry
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the etiological agent for the Coronavirus Disease 2019 (COVID‐19). The COVID‐19 pandemic has created unimaginable and unprecedented global health crisis. Since the outbreak of COVID‐19, millions of dollars have been spent, hospitalization overstretched with increasing morbidity and mortality. All these have resulted in unprecedented global economic catastrophe. Several drugs and vaccines are currently being evaluated, tested, and administered in the frantic efforts to stem the dire consequences of COVID‐19 with varying degrees of successes. Zinc possesses potential health benefits against COVID‐19 pandemic by improving immune response, minimizing infection and inflammation, preventing lung injury, inhibiting viral replication through the interference of the viral genome transcription, protein translation, attachment, and host infectivity. However, this review focuses on the various mechanisms of action of zinc and its supplementation as adjuvant for vaccines an effective therapeutic regimen in the management of the ravaging COVID‐19 pandemic. Practical applications The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the etiological agent for the Coronavirus Disease 2019 (COVID‐19), has brought unprecedented untold hardship to both developing and developed countries. The global race for vaccine development against COVID‐19 continues with success in sight with attendant increasing hospitalization, morbidity, and mortality. Available drugs with anti‐inflammatory actions have become alternative to stem the tide of COVID‐19 with attendant global financial crises. However, Zinc is known to modulate several physiological functions including intracellular signaling, enzyme function, gustation, and olfaction, as well as reproductive, skeletal, neuronal, and cardiovascular systems. Hence, achieving a significant therapeutic approach against COVID‐19 could imply the use of zinc as a supplement together with available drugs and vaccines waiting for emergency authorization to win the battle of COVID‐19. Together, it becomes innovative and creative to supplement zinc with currently available drugs and vaccines.<br />Dietary supplementation of Zinc could, therefore, be of immense benefits during the COVID‐19 pandemic due to its array of biological and pharmacological properties which include anti‐inflammatory, antioxidant, antiflu, antimicrobial, wound healing, antiaging, and a signaling molecule. Drugs such as chloroquine, and flavonoids including quercetin and epigallocatechin‐gallate act as facilitators and enhance the entry of zinc into the cell, and are, therefore, known as zinc ionophores. Hence, combining Zn as part of drug regimen for COVID‐19 could offer significant therapeutic advantage for the successful management of global COVID‐19 crisis.

Details

Language :
English
ISSN :
17454514 and 01458884
Database :
OpenAIRE
Journal :
Journal of Food Biochemistry
Accession number :
edsair.doi.dedup.....8c4347f1595f22505bd31ae2963d7d95
Full Text :
https://doi.org/10.1111/jfbc.13604